Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Cell Cycle (Georgetown, Tex.)
|
August 25, 2012
Directing p53 to induce autophagy
Lindsey D Mayo
EMBO Molecular Medicine
|
August 17, 2023
Alteration of tumor suppressors changes the endometrial tumor spectrum
Lindsey D Mayo
Trends in Biochemical Sciences
|
September 10, 2002
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
Lindsey D Mayo, David B Donner
International Journal of Molecular Sciences
|
December 5, 2012
Integration of DNA damage and repair with murine double-minute 2 (Mdm2) in tumorigenesis
Jason A Lehman, Lindsey D Mayo
International Journal of Molecular Sciences
|
November 30, 2016
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
David J Olivos, Lindsey D Mayo
Cell Cycle (Georgetown, Tex.)
|
March 23, 2010
Inactivation of p53 signaling by p73 or PTEN ablation results in a transformed phenotype that remains susceptible to Nutlin-3 mediated apoptosis
Rocky Cipriano, John T Patton, Lindsey D Mayo, et al.
Oncogene
|
June 20, 2020
Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors
Eric R Wolf, Alexander R Mabry, Blossom Damania, et al.
Journal of Leukocyte Biology
|
February 8, 2006
p53 regulates Btk-dependent B cell proliferation but not differentiation
Nathan W Schmidt, Lindsey D Mayo, David B Donner, et al.
Cancer Research
|
July 4, 2003
PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment
Jing Dong Su, Lindsey D Mayo, David B Donner, et al.
Expert Opinion on Drug Discovery
|
September 10, 2009
Therapeutic considerations for Mdm2: not just a one trick pony
Jason A Lehman, Jacob A Eitel, Christopher N Batuello, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Cell Cycle (Georgetown, Tex.)
|
August 25, 2012
Directing p53 to induce autophagy
Lindsey D Mayo
EMBO Molecular Medicine
|
August 17, 2023
Alteration of tumor suppressors changes the endometrial tumor spectrum
Lindsey D Mayo
Trends in Biochemical Sciences
|
September 10, 2002
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
Lindsey D Mayo, David B Donner
International Journal of Molecular Sciences
|
December 5, 2012
Integration of DNA damage and repair with murine double-minute 2 (Mdm2) in tumorigenesis
Jason A Lehman, Lindsey D Mayo
International Journal of Molecular Sciences
|
November 30, 2016
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
David J Olivos, Lindsey D Mayo
Cell Cycle (Georgetown, Tex.)
|
March 23, 2010
Inactivation of p53 signaling by p73 or PTEN ablation results in a transformed phenotype that remains susceptible to Nutlin-3 mediated apoptosis
Rocky Cipriano, John T Patton, Lindsey D Mayo, et al.
Oncogene
|
June 20, 2020
Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors
Eric R Wolf, Alexander R Mabry, Blossom Damania, et al.
Journal of Leukocyte Biology
|
February 8, 2006
p53 regulates Btk-dependent B cell proliferation but not differentiation
Nathan W Schmidt, Lindsey D Mayo, David B Donner, et al.
Cancer Research
|
July 4, 2003
PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment
Jing Dong Su, Lindsey D Mayo, David B Donner, et al.
Expert Opinion on Drug Discovery
|
September 10, 2009
Therapeutic considerations for Mdm2: not just a one trick pony
Jason A Lehman, Jacob A Eitel, Christopher N Batuello, et al.
Page
of 6